Sort
82,697 grants matching “vaccine development”
PET Probes Targeting Immune Cells for Imaging Tuberculosis
$692,236Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
PET Probes Targeting Immune Cells for Imaging Tuberculosis
$692,236Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Molecular Basis of Host-Filovirus Interactions in Pathogenesis
$692,229Hideki Ebihara · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
HIV-1 Genetic Variation in Infected Individuals
$692,219Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
IMMUNOLOGIC RELATEDNESS AMONG AND BETWEEN HIV1 CLADES
$692,196New York University School Of Medicine · R01 · FY2002 · AI
DsRNA Characterization in Monkeypox-infected Cells
$692,150Bertram L. Jacobs · Arizona State University-Tempe Campus · R01 · FY2015 · AI
A spatially organized microphysiological model of a human lymph node
$692,129Rebecca R Pompano · University Of Virginia · U01 · FY2022 · EB
A spatially organized microphysiological model of a human lymph node
$692,129Rebecca R Pompano · University Of Virginia · U01 · FY2023 · EB
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
$692,102David Baker · University Of Washington · R01 · FY2024 · AI
Structural characterization of native HBV capsids and virions from human cells
$692,089Che-Yen Wang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · AI
Structural characterization of native HBV capsids and virions from human cells
$692,089Che-Yen Wang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · AI
Personalized Adoptive T-cell Therapy for AML
$692,077David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
$692,067Jinhong Chang · Baruch S. Blumberg Institute · R01 · FY2021 · AI
Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells
$692,040Jacques F Banchereau · Jackson Laboratory · U01 · FY2016 · AI
Oral immunization against HIV/AIDS with prime-boost strategies
$692,038Shiu-Lok Hu · University Of Washington · R01 · FY2013 · DE
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial
$691,976Chun R. Chao · Kaiser Foundation Research Institute · R01 · FY2021 · CA
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
$691,914John L Schroeder · Dnastar, Inc. · R44 · FY2025 · GM
Centralized IIS-Based Reminder-Recall to Increase Influenza Vaccination Rates
$691,887Allison Kempe · University Of Colorado Denver · R01 · FY2016 · AI
Penile transmission and neutralization of pathogenic SIVsmm
$691,804George M Shaw · University Of Pennsylvania · R01 · FY2013 · AI
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$691,776Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2024 · FD
The Protective and Pathologic Features of the EVD Survivor Immune System
$691,767William Fischer · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$691,756William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Establishment of a SPF Rhesus Macaque Colony
$691,751Larry Bill Cummins · Texas Biomedical Research Institute · U42 · FY2010 · RR
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$691,699William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2022 · AI
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$691,684William Robert Jacobs · Albert Einstein College Of Medicine · R01 · FY2020 · AI